Ignite Creation Date:
2025-12-24 @ 4:55 PM
Ignite Modification Date:
2025-12-24 @ 4:55 PM
Study NCT ID:
NCT04511650
Status:
TERMINATED
Last Update Posted:
2023-06-08
First Post:
2020-08-07
Is Possible Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Evaluation of the Safety and Efficacy of Razuprotafib in Hospitalized Subjects With Coronavirus Disease 2019
Sponsor:
EyePoint Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-10-21
Start Date Type:
ACTUAL
Primary Completion Date:
2021-02-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-02-26
Completion Date Type:
ACTUAL
First Submit Date:
2020-08-07
First Submit QC Date:
None
Study First Post Date:
2020-08-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-09-19
Results First Submit QC Date:
None
Results First Post Date:
2023-06-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-06
Last Update Post Date:
2023-06-08
Last Update Post Date Type:
ACTUAL